Dual Action Efficiency: As a GIP/GLP-1 dual-action medication, tirzepatide targets multiple metabolic pathways, potentially leading to superior effectiveness
Unexpected side effects Gastrointestinal issues: Nausea, cramping, changes in appetite rarely reported
First, Wegovy is a drug shown to help people lose weight, often combined with a reduced-calorie meal plan and increased physical activity
There is some interest in magnesium for migraine prophylaxis, though the evidence is of low quality and NICE does not currently recommend routine magnesium supplementation for migraine prevention
Versus placebo, tirzepatide was more efficacious in reducing body weight (-10.96Kg, -8.75Kg, and -6.16Kg for tirzepatide 15, 10, and 5mg respectively) than semaglutide (-5.24Kg, -4.44Kg, and -2.72Kg for semaglutide 2.0, 1.0, and 0.5mg respectively)
Thus, the high concentrations of GSH observed during autumn, compared with those observed during the other seasons, could have increased to achieve an oxidative balance and physiologically counteract the high production of ROS
